DEXAMETHASONE 0.1%w/v IP + TOBRAMYCIN SULPHATE 0.3%w/v IP + BENZALKONIUM CHLORID...

A combinational ophthalmic medication that treats or prevents infection and inflammation. (Charles L Balzli, 2010) An appropriate option for inflammatory ocular conditions where the risk of bacterial ocular infection exists. (Stephen V Scoper, 2008) A potent antibacterial agent that provides coverage against a broad spectrum of common ocular pathogens. (Karpecki, 2021) Effectively controls ocular inflammation and reduces ocular bacterial flora. Shows outstanding antibacterial effects against Pseudomonas, Staphylococcus aureus, and many members of the Enterobacteriaceae family. (Qin Xiang, 2019) A safe and well-tolerated agent for the prevention of post-surgical inflammation following cataract extraction. (Ricardo Notivol & Group, 2004) Reduces postoperative inflammation and prevents postoperative ocular infections. Effectively controls inflammation by inhibiting the release of inflammatory mediators, which induce discomfort and inflammation in the eye. Eases inflammation, stiffness, pain, and irritation caused by the infection. Suppresses the inflammatory response and protects against infection by susceptible strains of Gram-positive and Gram-negative microorganisms. (Rachel Andrew, 2012)